Almac Group has announced the official opening of a new, state-of-the-art, £65m commercial manufacturing facility for Almac Pharma Services at its global headquarters in Craigavon, Northern Ireland. The new 100,000sq ft facility enhances existing capabilities in commercial manufacture of oral dose treatments for a va…
Merck, known as MSD outside of the United States and Canada, announced the opening of a new, $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina, site. This expansion of our Durham plant is a crucial component of the more than $12 billion Merck has invested toward…
Motivity, a leading provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers who treat children with autism, announced a $27 million investment from Five Elms Capital, a leading software investment firm. The funding will enable Motivity to accelerate product innovation, expand its team, and st…
Entos Pharmaceuticals (Entos), announced a $62 million investment from the Government of Canada. This further leverages the previously announced $15.5 million awarded to Entos from the Government of Alberta. The $77.5 million total investment will support a $198.5 million project to create a state-of-the-art R&D …
Syngene International Limited ('Syngene'), a global contract research, development, and manufacturing organization (CRDMO) announced the acquisition of its first biologics site in the USA – fitted with multiple monoclonal antibody (mAbs) manufacturing lines. Syngene's investment in its first facility in the United St…
ASHP (American Society of Health-System Pharmacists) announced a partnership with ShiftRx, the first-in-market pharmacy staffing and workforce management platform, to further their shared commitment to uplifting the pharmacy workforce and delivering high-quality patient care across all healthcare settings. "ASHP has …
Axplora, a global leader in API small molecule and ADC (antibody-drug conjugate) manufacturing, is strengthening its leading position in the commercial manufacturing of ADCs with the launch of a cutting-edge payload manufacturing workshop at its Le Mans site (France). This expansion, which is part of the France 2030 p…
CordenPharma is pleased to share significant progress on its growth initiatives with a >€1 billion strategic investment in peptide development and manufacturing. The company's ambitious expansion plans are set to propel its Peptide Platform business beyond the €1 billion sales milestone by 2028, reinforcing CordenP…
Bionova Scientific, an Asahi Kasei company and boutique commercial-scale biologics contract development and manufacturing organization (CDMO), has announced the opening of a new facility in Fremont, California. The 55,000 sq. ft. process development and pilot plant will significantly expand the company’s ability to ad…
Eli Lilly and Company announced at a press conference in Washington, D.C., plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical manufacturing sites in the United States. This brings the company's total U.S. capital expansion commitments to more than $50 billion…
Page 28 of 61